Literature DB >> 15222480

The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1.

Ben Berkhout1, René Floris, Isidra Recio, Servaas Visser.   

Abstract

Milk forms a rich source of biologically interesting components and the protein fraction is known to facilitate many different biological functions. In this manuscript, we review the antiviral properties of the milk protein lactoferrin (LF). In particular, we will describe its antiviral activity against the human immunodeficiency virus type 1 (HIV-1).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222480     DOI: 10.1023/b:biom.0000027707.82911.be

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  12 in total

1.  Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.

Authors:  Richard M Novak; Betty A Donoval; Parrie J Graham; Lucy A Boksa; Gregory Spear; Ronald C Hershow; Hua Yun Chen; Alan Landay
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

Review 2.  Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications.

Authors:  Barbara L Shacklett; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

3.  Monitoring lactoferrin iron levels by fluorescence resonance energy transfer: a combined chemical and computational study.

Authors:  Fernando Carmona; Víctor Muñoz-Robles; Rafael Cuesta; Natividad Gálvez; Mercè Capdevila; Jean-Didier Maréchal; José M Dominguez-Vera
Journal:  J Biol Inorg Chem       Date:  2014-01-18       Impact factor: 3.358

4.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

5.  Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization.

Authors:  Mohammad-Ali Jenabian; Héla Saïdi; Charlotte Charpentier; Hicham Bouhlal; Dominique Schols; Jan Balzarini; Thomas W Bell; Guido Vanham; Laurent Bélec
Journal:  AIDS Res Ther       Date:  2010-06-14       Impact factor: 2.250

6.  Mucosal immunity to HIV: a review of recent literature.

Authors:  Barbara L Shacklett
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

Review 7.  Cell-mediated immunity to HIV in the female reproductive tract.

Authors:  Barbara L Shacklett
Journal:  J Reprod Immunol       Date:  2009-10-25       Impact factor: 4.054

8.  Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma.

Authors:  Julie A Martellini; Amy L Cole; Nitya Venkataraman; Gerry A Quinn; Pavel Svoboda; Bhushan K Gangrade; Jan Pohl; Ole E Sørensen; Alexander M Cole
Journal:  FASEB J       Date:  2009-06-01       Impact factor: 5.191

9.  Health-Related Aspects of Milk Proteins.

Authors:  Seyed Hossein Davoodi; Roghiyeh Shahbazi; Saeideh Esmaeili; Sara Sohrabvandi; AmirMohamamd Mortazavian; Sahar Jazayeri; Aghdas Taslimi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

Review 10.  Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.

Authors:  Francesco Giansanti; Gloria Panella; Loris Leboffe; Giovanni Antonini
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.